© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
June 13, 2019
Both responder and remitter patients experienced a statistically significant longer time to relapse with esketamine compared to the placebo
October 01, 2018
FDA approves lofexidine for opioid withdrawal symptoms.